Fundraising Fox

Kevin Bitterman

Investor

Partner at Atlas Venture · Board director at Renasant Bio · Director of the Issuer at Kinaset Therapeutics · Board director at Remix Therapeutics

Cambridge, Massachusetts

Writes $10M – $50M checks · typically $25M

About

Kevin Bitterman invests in and helps build companies that turn scientific research into new medicines. He was the founding CEO of Editas Medicine, Morphic Therapeutic (acquired by Lilly), and Visterra (acquired by Otsuka), and joined Atlas Venture in 2017 after serving as a partner on the healthcare team at Polaris Partners since 2004. He holds a BA in biology from Rutgers University and a PhD in genetics from Harvard Medical School.

Contact· self-published, not guessed

Likely emails· guessed from name + firm domain, not firm-published

Invests in

Biotech

Board director at Renasant Bio

Intro paths

→

In turn, Kevin can intro founders to Renasant Bio's investors below.

Renasant Bio's investors · 4

5AM VenturesBoston · $100K – $4M checks · since 2025Atlas VentureCambridge · $500K – $1M checks · since 2025OrbiMedNew York · $1M – $75M checks · since 2025Qiming Venture Partners USACambridge · since 2025

Co-founders at Renasant Bio

JR
Jeremy ReiterScientific Co-Founder
MD
Markus DellingScientific Co-Founder

Director of the Issuer at Kinaset Therapeutics

Intro paths

→

In turn, Kevin can intro founders to Kinaset Therapeutics's investors below.

Kinaset Therapeutics's investors · 8

5AM VenturesBoston · $100K – $4M checks · since 2020Atlas VentureCambridge · $500K – $1M checks · since 2022EQT Life SciencesLuxembourg · $11M – $66M checks · since 2020GimvAntwerp · $21M – $430M checks · since 2026RA CapitalBoston · since 2020Sixty Degree CapitalNorth York · since 2020Vivo CapitalPalo Alto · $10M – $50M checks · since 2020Willett AdvisorsNew York · since 2026

Co-founders at Kinaset Therapeutics

RH
Roger HeermanChief Business/Operating Officer / Co-Founder
FMFrazer Morgan
Frazer MorganChief Development Officer / Co-Founder
RCRobert Clarke
Robert ClarkeChief Executive Officer / Board Member / Co-Founder

Board director at Remix Therapeutics

Intro paths

→

In turn, Kevin can intro founders to Remix Therapeutics's investors below.

Remix Therapeutics's investors · 5

ARCH Venture PartnersChicago · $50K – $250M checks · since 2023Atlas VentureCambridge · $500K – $1M checks · since 2024Decheng CapitalMenlo Park · since 2023Foresite CapitalWest Hollywood · since 2024The Column GroupSan Francisco · $30M checks · since 2024

Co-founders at Remix Therapeutics

PS
Peter Smith, PhDCo-Founder, President and Chief Executive Officer
PS
Peter SmithCo-Founder, President and Chief Executive Officer

Experience

  1. Atlas VenturePartnercurrent2017 — presentCambridge, MA
  2. Judo BioBoard of Directorscurrent2022 — presentCambridge, Massachusetts, United States
  3. Remix TherapeuticsBoard of Directorscurrent2019 — presentCambridge, Massachusetts, United States
  4. nChroma BioBoard of Directorscurrent2020 — presentCambridge, Massachusetts, United States
  5. Kinaset TherapeuticsBoard of Directorscurrent2020 — presentBoston, Massachusetts, United States
  6. Disc MedicineBoard Of Directorscurrent2017 — presentCambridge, MA
  7. Isabella Stewart Gardner MuseumMember Board of Trusteescurrent2017 — presentBoston, Massachusetts, United States
  8. Mariana OncologyBoard of Directors2021 — 2024Cambridge, Massachusetts, United States
  9. New England Venture Capital AssociationBoard Member2013 — 2023Greater Boston Area
  10. Akero TherapeuticsBoard of Directors2018 — 2021Cambridge, MA
  11. Navitor PharmaceuticalsBoard of Directors2017 — 2020Cambridge, MA
  12. Editas MedicineBoard of Directors2014 — 2018Cambridge, MA
  13. Editas MedicineFounding CEO2013 — 2014Cambridge, MA
  14. Morphic TherapeuticBoard of Directors2015 — 2017Waltham, MA
  15. Morphic TherapeuticFounding CEO2014 — 2015Greater Boston Area
  16. Vets First ChoiceBoard of Directors2012 — 2017
  17. Neuronetics, Inc.Board of Directors2011 — 2017
  18. Polaris PartnersPartner2004 — 2017Greater Boston Area
  19. Kala PharmaceuticalsBoard of Directors2009 — 2017
  20. Taris BiomedicalBoard of Directors2008 — 2017
  21. Genocea BiosciencesBoard of Directors2006 — 2017
  22. Visterra Inc.Board of Directors2009 — 2015

Skills & more

Venture Capital37Biotechnology72Medical Devices13Lifesciences41Technology Transfer25Commercialization58Molecular Biology5Biopharmaceuticals45Drug Discovery15Clinical Development9Clinical Trials4Genomics3
+12 moreCell BiologyStart-upsImmunologyVaccinesOncologyInfectious DiseasesDrug DevelopmentBiomarkersPharmaceutical IndustryFDARegulatory AffairsBiochemistry

From Kevin's professional profile.

Deals · 9

Renasant BioBoard seat

via Atlas Venture · filed Jul 2025 · $30M raise

GrobioBoard seat

via Atlas Venture · filed Jul 2024 · $60.4M raise

Chroma Medicine, Inc.Board seat

via Atlas Venture · filed Sep 2023 · $135M raise

Navitor PharmaceuticalsBoard seat

via Atlas Venture · filed May 2020 · $20.2M raise

Akero Therapeutics, Inc.Board seat

via Atlas Venture · filed Dec 2018 · $45.5M raise

Morphic Holding, Inc.Board seat

via Atlas Venture · filed Jul 2016 · $51.5M raise

KALA BIOBoard seat

via Atlas Venture · filed Aug 2015 · $7M raise

Direct Vet MarketingBoard seat

via Atlas Venture · filed Jul 2015 · $52.3M raise

NeuroneticsBoard seat

via Atlas Venture · filed May 2015 · $34.3M raise

press ↗

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Sources: the firm's website · SEC Form D filings.

Colleagues at Atlas Venture

Aimee Raleigh
Principal at Atlas Venture
Bruce Booth
Partner at Atlas Venture
Chelsea Johnson
Principal at Atlas Venture
David Grayzel
Partner at Atlas Venture
Jason Rhodes
Partner at Atlas Venture
Jean-François Formela
Partner at Atlas Venture
Jernej Godec
Principal at Atlas Venture
Jodie Morrison
Venture Partner at Atlas Venture

Network1

Dave Maki
Managing Partner at Altitude Ventures Management, Llc

Investors connected to Kevin in public investor directories — a warm-intro map.

Frequently asked questions

Who is Kevin Bitterman?
Kevin Bitterman invests in and helps build companies that turn scientific research into new medicines. He was the founding CEO of Editas Medicine, Morphic Therapeutic (acquired by Lilly), and Visterra (acquired by Otsuka), and joined Atlas Venture in 2017 after serving as a partner on the healthcare team at Polaris Partners since 2004. He holds a BA in biology from Rutgers University and a PhD in genetics from Harvard Medical School.
Where does Kevin Bitterman work?
Kevin Bitterman is Partner at Atlas Venture and Board director at Renasant Bio and Director of the Issuer at Kinaset Therapeutics and Board director at Remix Therapeutics.
What does Kevin Bitterman invest in?
Kevin Bitterman invests in Biotech.
What check size does Kevin Bitterman write?
Kevin Bitterman typically writes checks of $10M – $50M.
What boards does Kevin Bitterman sit on?
Kevin Bitterman holds tracked board seats at Akero Therapeutics, Akero Therapeutics, Inc., Chroma Medicine, Inc., Direct Vet Marketing, Disc Medicine, Grobio, Judo Bio, KALA BIO, Kinaset Therapeutics, Kinaset Therapeutics.
Where did Kevin Bitterman go to school?
Kevin Bitterman studied at Harvard Medical School (Ph.D., Genetics); Rutgers University (BA, Biology).

Founder mafias

Rutgers University mafia29

Also came through, then founded or led a company.

Ryan BednarBSFounded RankScience +1Harsh YadavMaster of ScienceFounded Ryse +1Anshu AgarwalMaster of Science - MSFounded NimbellaTino WakedBAFounded TAPTAPDave RosenbergB.A.Founded MuleSoftAlejandro MartíPcFounded Mitiga

+ 22 more

Harvard Medical School mafia28

Also came through, then founded or led a company.

Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3Lyle BerkowitzMedical informatics sub-fellowshipFounded Apollo Health +1Rushika FernandopulleM.D.Founded Iora HealthKush M ParmarMDFounded Homology MedicinesCarlos LoyaPhDFounded Aldebaran TherapeuticsJeffrey M. JonasMDFounded Sage Therapeutics

+ 21 more

Atlas Venture mafia13

Also came through, then founded or led a company.

Nessan BerminghamAnalyst - Associate - Principle - PartnerFounded Korro Bio +2Romesh SubramanianEntrepreneur In ResidenceFounded RaNA Therapeutics +2Phillip SamayoaVenture PartnerFounded Generation Bio +2Jason RhodesPartnerFounded Rectifypharma +1Sumit AgarwalAssociateFounded Shape Security +1John MaraganoreVenture PartnerFounded Alnylam

+ 6 more

Polaris Partners mafia3

Also came through, then founded or led a company.

Michael LangerInternFounded T.Rx CapitalAndrew BurtonAdvisorFounded Commercetools

Judo Bio mafia2

Also came through, then founded or led a company.

Jeff GoaterExecutive ChairFounded Atavistik Bio

Same school

Also attended Harvard Medical School143

Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital

+ 137 more

Also attended Rutgers University120

Jigar RaythathaInvestor at Third Rock VenturesRobin LiInvestor at GGV CapitalDominique LittleGovernment Affairs Lead at ParadigmGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersMark FieldsInvestor at Alsop Louie PartnersBasil AlomaryPrincipal, Head of Research & Growth Strategy at Stripes

+ 114 more

Shared employers

Also worked at nChroma Bio1

Mansi ShindeVice President of Company Creation at Frazier Life Sciences

Also worked at Morphic Therapeutic4

Amir NashatEntrepreneur partner at Polaris Partners focused on healthcare investing and portfolio company executive rolesVikas GoyalPartner at Longwood FundMargarita ChavezManaging Director at AbbVieChristopher O'DonnellPartner at Pfizer Venture Investments

Also worked at Neuronetics, Inc.1

Leslie BottorfGE Healthcare Ventures, Medtronics at Good AI Capital

Also worked at Polaris Partners32

Dylan PearcePartner at GreycroftGraham BrownManaging Partner at Lerer HippeauMichael GreeleyCo-Founder and General Partner at Flare Capital PartnersSimeon SimeonovAdvisor at One Way VenturesDave BarrettSenior Advisory Partner at Polaris PartnersAlexandra CantleyManaging Partner at Polaris Partners

+ 26 more